NMN for Blood NAD+ and NMN
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Evidence brief
NMN for Blood NAD+
Evidence grade B — Reliably raised
Grade B1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Compound or practice
NMN
An NAD+ precursor with real biomarker effects (NAD+ rises) and no proven clinical or longevity outcomes yet.
Grade C2 graded outcomesrevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | NMN for Blood NAD+ | NMN |
|---|---|---|
| Blood NAD+ | Evidence grade BModerate effecthighReliably raised | Evidence grade BModerate effecthighReliably raised |
Graded only in NMN for Blood NAD+
None — every outcome it grades is graded in both.
Graded only in NMN
- Physical function / insulin sensitivity Small effectEvidence grade C
What each entry says about the other
- NMN for Blood NAD+’s entry · Goes with: Read the full NMN monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.